About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Palliative Care for Heart Failure Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01519479

Palliative Care for Heart Failure Patients

The purpose of this study is to assess the impact of palliative care consultation on quality of life and symptom management for patients hospitalized with acute heart failure with a randomized control...

Lead sponsor: Allina Health System•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Allina Health System

Research questions: Q1. Does the provision of palliative care to heart failure patients yield higher quality of life, increased symptom management, or reduced depression compared to heart failure patients not receiving palliative care? Q2. Does the provision of palliative care to heart failure patients result in differential use of medical services (lower hospital days and readmission) compared to heart failure patients not receiving systematic palliative care?

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Abbott Northwestern Hospital inpatient adults with a diagnosis of acute heart failure

Exclusion Criteria

•Are not an inpatient at Abbott Northwestern Hospital
•Are in the ICU
•On a ventilator
•Are pre-or post heart transplant
•Have a ventricular assist device (VAD)
•Determined to be actively dying
•Have cognitive impairments such that informed consent would not be possible,
•Are not proficient in the English language

Related studies

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

NCT07550790 · Heart Failure Acute, Renal Dysfunction

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction

A Study of Paramedic HF Management

NCT06874556 · Heart Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 18, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment232

Start dateApr 2012

Last updatedMar 18, 2019

Condition

Locations shown

Abbott Northwestern Hospital

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 18, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions